相关实验视频

Updated: Sep 10, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K

病例报告:双边同步原发性非小细胞肺癌患者有两种不同的EGFR突变

Thanh-Dung Quach1,2, Kien Hung Do3, Dinh Tung Nguyen1,2

  • 1Oncology Center, Vinmec Times City International Hospital, Vinmec Healthcare System, Hanoi, Vietnam.

Cancer reports (Hoboken, N.J.)
|August 26, 2025
PubMed
概括

本病例研究详细介绍了两种不同表皮生长因子受体 (EGFR) 突变的双边非小细胞肺癌 (NSCLC) 的罕见实例. 对于有效的NSCLC治疗策略来说,全面的分子分析至关重要.

关键词:
发生EGFR突变亚法替尼非小细胞肺癌

更多相关视频

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.9K
Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.7K

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K